Semin Oncol. 2001 Aug;28(4 Suppl 13):19-23.

New approaches for temozolomide therapy: use in newly diagnosed glioma.

Source

University Hospital CHUV, Lausanne, Switzerland.

Abstract

Temozolomide is a novel oral alkylating agent that has been approved for the treatment of patients with refractory malignant glioma. Treatment with temozolomide is now being explored in patients with newly diagnosed malignant glioma in several ongoing clinical trials, and alternative treatment schedules are being evaluated. A schedule of continuous daily treatment with temozolomide for 6 or 7 weeks has been developed and determined to be safe, effective, and well tolerated. When temozolomide was continuously given along with a standard course of radiation therapy for 6 or 7 weeks, followed by adjuvant treatment with temozolomide, promising preliminary results were seen in patients with malignant gliomas.

PMID:: 11550135; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

DACARBAZINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Future directions for temozolomide therapy. [Semin Oncol. 2001]
Review Future directions for temozolomide therapy.
Yung WK. Semin Oncol. 2001 Aug; 28(4 Suppl 13):43-6.
Review Optimal role of temozolomide in the treatment of malignant gliomas. [Curr Neurol Neurosci Rep. 2005]
Review Optimal role of temozolomide in the treatment of malignant gliomas.
Stupp R, van den Bent MJ, Hegi ME. Curr Neurol Neurosci Rep. 2005 May; 5(3):198-206.
Review Temozolomide: a novel oral alkylating agent. [Expert Rev Anticancer Ther. 2001]
Review Temozolomide: a novel oral alkylating agent.
Danson SJ, Middleton MR. Expert Rev Anticancer Ther. 2001 Jun; 1(1):13-9.
Review Current and future developments in the use of temozolomide for the treatment of brain tumours. [Lancet Oncol. 2001]
Review Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R, Gander M, Leyvraz S, Newlands E. Lancet Oncol. 2001 Sep; 2(9):552-60.
Review The use of temozolomide in recurrent malignant gliomas. [Cancer Treat Rev. 2002]
Review The use of temozolomide in recurrent malignant gliomas.
Gaya A, Rees J, Greenstein A, Stebbing J. Cancer Treat Rev. 2002 Apr; 28(2):115-20.

See reviews... See all...

Cited by 1 PubMed Central article

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol. [BMC Cancer. 2006]
Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.
Combs SE, Heeger S, Haselmann R, Edler L, Debus J, Schulz-Ertner D. BMC Cancer. 2006 May 18; 6:133. Epub 2006 May 18.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

New approaches for temozolomide therapy: use in newly diagnosed glioma.
New approaches for temozolomide therapy: use in newly diagnosed glioma.
Semin Oncol. 2001 Aug ;28(4 Suppl 13):19-23.

PubMed
The effect of supplementary antioxidant therapy in patients who report hypersens...
The effect of supplementary antioxidant therapy in patients who report hypersensitivity to electricity: a randomized controlled trial.
MedGenMed. 2001 Mar 23 ;3(2):11.

PubMed
Nomenclature of the human immunoglobulin kappa (IGK) genes.
Nomenclature of the human immunoglobulin kappa (IGK) genes.
Exp Clin Immunogenet. 2001 ;18(3):161-74.

PubMed
Neural correlates of conscious self-regulation of emotion.
Neural correlates of conscious self-regulation of emotion.
J Neurosci. 2001 Sep 15 ;21(18):RC165.

PubMed
Markers of inflammation and cellular adhesion molecules in relation to insulin r...
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study.
J Clin Endocrinol Metab. 2001 Sep ;86(9):4398-405.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: